de Groot, A. F.
Blok, E. J.
Charehbili, A.
Engels, C. C.
Smit, V. T. H. B. M.
Dekker-Ensink, N. G.
Putter, H.
Meershoek-Klein Kranenbarg, E.
van de Velde, C. J. H.
Liefers, G. J.
Nortier, J. W. R.
Kuppen, P. J. K.
van der Burg, S. H.
Kroep, J. R.
Funding for this research was provided by:
Dutch Cancer Society
Novartis
Amgen
Sanofi
Article History
Received: 6 December 2018
Accepted: 5 March 2019
First Online: 13 March 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The NEOZOTAC trial was approved by the Medical Ethical Committee of the Leiden University Medical Center.
: Informed consent was obtained from all individual participants included in the study.